全文获取类型
收费全文 | 10514篇 |
免费 | 608篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 94篇 |
儿科学 | 189篇 |
妇产科学 | 281篇 |
基础医学 | 1622篇 |
口腔科学 | 115篇 |
临床医学 | 958篇 |
内科学 | 2011篇 |
皮肤病学 | 268篇 |
神经病学 | 1137篇 |
特种医学 | 523篇 |
外科学 | 1637篇 |
综合类 | 39篇 |
一般理论 | 1篇 |
预防医学 | 413篇 |
眼科学 | 182篇 |
药学 | 766篇 |
中国医学 | 8篇 |
肿瘤学 | 914篇 |
出版年
2022年 | 85篇 |
2021年 | 131篇 |
2020年 | 108篇 |
2019年 | 149篇 |
2018年 | 169篇 |
2017年 | 166篇 |
2016年 | 215篇 |
2015年 | 212篇 |
2014年 | 288篇 |
2013年 | 370篇 |
2012年 | 501篇 |
2011年 | 623篇 |
2010年 | 384篇 |
2009年 | 391篇 |
2008年 | 600篇 |
2007年 | 666篇 |
2006年 | 631篇 |
2005年 | 638篇 |
2004年 | 626篇 |
2003年 | 596篇 |
2002年 | 546篇 |
2001年 | 245篇 |
2000年 | 232篇 |
1999年 | 205篇 |
1998年 | 139篇 |
1997年 | 133篇 |
1996年 | 99篇 |
1995年 | 91篇 |
1994年 | 71篇 |
1993年 | 81篇 |
1992年 | 131篇 |
1991年 | 120篇 |
1990年 | 108篇 |
1989年 | 104篇 |
1988年 | 85篇 |
1987年 | 62篇 |
1986年 | 64篇 |
1985年 | 86篇 |
1984年 | 55篇 |
1983年 | 72篇 |
1982年 | 42篇 |
1981年 | 53篇 |
1980年 | 42篇 |
1979年 | 61篇 |
1978年 | 51篇 |
1977年 | 49篇 |
1976年 | 47篇 |
1975年 | 38篇 |
1974年 | 38篇 |
1973年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Lucia Nogovà MD Volker Diehl MD Andreas Engert MD 《Current hematologic malignancy reports》2006,1(1):60-65
Lymphocyte-predominant Hodgkin’s lymphoma (LPHL) differs in histologic and clinical presentation from classical Hodgkin’s
lymphoma (cHL). Treatment of LPHL patients using standard Hodgkin’s lymphoma protocols leads to complete remission in more
than 95% of patients. Survival and freedom from treatment failure are substantially worse in advanced-stage patients than
for early-stage patients. Thus, patients in advanced stages and those in early stages with unfavorable risk factors should
be treated similar to those with cHL. In contrast, patients with early-stage LPHL without risk factors might be sufficiently
treated with reduced-intensity programs having less severe adverse effects. As a result, treatment of early LPHL is rather
heterogeneous, including radiotherapy using extended-fleld technique, involved-fleld radiotherapy (IF-RT), combined-modality
treatment, and, more recently, monoclonal antibodies. Watch-and-wait strategy plays an important role in pediatric oncology,
to avoid adverse effects associated with therapy. IF-RT seems to be emerging as a treatment of choice for patients with stage
IA LPHL; most larger study groups, such as the German Hodgkin Study Group and the European Organisation for Research and Treatment
of Cancer, have adopted IF-RT as the treatment of choice for these patients. 相似文献
3.
We evaluated the acquisition and performance of a high-precision locomotor task in patients with Parkinson's disease (PD) and healthy subjects. All subjects walked on a treadmill and had to step repetitively as low as possible over an obstacle without touching it. During blocks 1 and 2, the subjects had full vision and received additional acoustic warning and feedback signals. During block 3, vision became restricted. Changes in foot clearance and the number of obstacle hits were evaluated. Initially, PD patients performed poorer and improved foot clearance slower. After task repetition, the groups performed similarly. Restricting vision deteriorated performance in both groups. The similar performance of PD patients after task repetition might indicate that adequate training could improve adaptive locomotor behavior in PD patients. 相似文献
4.
J M Esteban J A Kuhn B Felder J Y Wong H Battifora J D Beatty P M Wanek J E Shively 《Cancer research》1991,51(14):3802-3806
We have previously shown that the colon carcinoma (LS174T) xenografts that emerged shortly after radioimmunotherapy with 90Y-labeled anti-CEA monoclonal antibody (MAb) ZCE025 lacked significant expression of CEA in comparison with the untreated tumors. The present study was designed to establish if the immunophenotype of the treated tumors was the result of CEA specific therapy and if the effect was permanent. Athymic mice bearing LS174T tumors were treated either with 120 mu Ci of 90Y-ZCE025, an equal dose of 90Y-96.5 (nonspecific MAb), or received no treatment. When the treated tumors grew to approximately 1.5 cm in diameter (6 weeks after therapy), they were resected and aliquoted to be transplanted to other mice, plated in tissue culture, fixed in formalin, and homogenized for CEA quantitation. The procedure was repeated 3 times (a total of 4 months after treatment). The CEA content was evaluated 2 and 6 weeks after therapy and when the tumors were transplanted. We confirmed a 4-fold decrease of CEA in the resurgent tumors 6 weeks after specific 90Y-ZCE025 therapy, which was twice the decrease experienced by the tumors treated with nonspecific 90Y-96.5, indicating substantial and specific killing of CEA-expressing cells. The CEA content slowly but progressively increased with each new pass of the tumor in the mice, reaching approximately one-half the value of the controls at the end of the study. The resurgent tumors were also studied by immunohistochemistry with MAbs detecting different epitopes of CEA, keratin, TAG-72, and epithelial membrane antigen to evaluate possible additional immunophenotypic changes induced by radioimmunotherapy. Only the expression of TAG-72 (recognized by MAb B72.3) increased immediately after therapy, but it returned to the original levels by the end of the study. These results suggest that: (a) specific radioimmunotherapy with 90Y-ZCE025 selectively kills cells that express higher levels of CEA; (b) the immunophenotype of the surviving fraction of the tumor appears to slowly revert to its original form; and (c) other tumor markers unrelated to CEA can also be affected. These observations have important implications for the design of radioimmunotherapy trials. 相似文献
6.
7.
D S Rao R Antonelli K R Kane J E Kuhn C Hetnal 《Henry Ford Hospital medical journal》1991,39(1):41-44
Coexistent primary hyperparathyroidism and monoclonal gammopathy, although rare, has been reported previously by a number of investigators. We report four patients with such an occurrence who were seen between 1976 and 1988. Another patient with primary hyperparathyroidism also had multiple myeloma and was in remission for 12 years. These patients represent approximately 1% of the 386 patients with primary hyperparathyroidism seen during the same 12-year period. Although several mechanisms have been proposed to explain this concurrence, we believe it is the result of a chance occurrence. A review of the literature, an estimate of the chance occurrence of coincidental monoclonal gammopathy, benign or malignant, in patients with primary hyperparathyroidism, and some practical implications of this interesting coexistence are presented. 相似文献
8.
Dr. med. H. Kuhn Dr. med. R. Gerdes-Kuhn Prof. Dr. med. H.-H. Küster 《Fu? & Sprunggelenk》2007,5(1):26-31
The Cinderella shoe syndrome specifies a commonly observed, not yet labeled disproportion of footwear and the morphologic conditions of the wearer. Disproportioned shoes and socks are worn–frequently unconsciously–due to personal reasons, fashion trends, misinformation and wrong advice; they can induce severe foot disorders. The Cinderella shoe syndrome has an important significance within the development, the treatment and the recurrence-prophylaxis of foot disorders, as well as in the assessment of possible reasons for recurrence after foot surgery. To recognize it, to treat individual psychologic reasons, to give support in the choice of footwear, to inform about and to change social reasons are all challenges of the foot surgeon. 相似文献
9.
10.
Uta Kraus-Tiefenbacher Lelia Bauer Antonella Scheda Carola Schoeber Joerg Schaefer Volker Steil Frederik Wenz 《BMC cancer》2007,7(1):178